Evidence map›Paper›PMID 29208163›Full record

ArticleMicrobial genomics2017

Population structure of Escherichia coli O26 : H11 with recent and repeated stx2 acquisition in multiple lineages.

Yoshitoshi Ogura, Yasuhiro Gotoh, Takehiko Itoh, Mitsuhiko P Sato, Kazuko Seto, Shyuji Yoshino, Junko Isobe, Yoshiki Etoh, Mariko Kurogi, Keiko Kimata and 14 more

Open access · goldAbstract read
In one paragraph

Article in Microbial genomics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Emerging hybrid shigatoxigenic and enteropathogenicClinical microbiology reviews · 2025
    Review
  7. Shiga toxin-producingFrontiers in microbiology · 2025
    Article
  8. Article
  9. Shiga Toxin-ProducingMicroorganisms · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 14 institutions in 2 countries.

Yoshitoshi Ogura1​Kyushu University, Fukuoka, Japan.
Yasuhiro Gotoh1​Kyushu University, Fukuoka, Japan.
Takehiko Itoh2​Tokyo Institute of Technology, Tokyo, Japan.
Mitsuhiko P Sato1​Kyushu University, Fukuoka, Japan.
Kazuko Seto3​Osaka Prefectural Institute of Public Health, Osaka, Japan.
Shyuji Yoshino4​Miyazaki Prefectural Institute for Public Health and Environment, Miyazaki, Japan.
Junko Isobe5​Toyama Institute of Health, Toyama, Japan.
Yoshiki Etoh6​Fukuoka Institute of Health and Environmental Sciences, Fukuoka, Japan.
Mariko Kurogi4​Miyazaki Prefectural Institute for Public Health and Environment, Miyazaki, Japan.
Keiko Kimata5​Toyama Institute of Health, Toyama, Japan.
Eriko Maeda6​Fukuoka Institute of Health and Environmental Sciences, Fukuoka, Japan.
Denis Piérard7​Universitair Ziekenhuis Brussel, Brussels, Belgium.
Masahiro Kusumoto8​National Institute of Animal Health, National Agriculture and Food Research Organization, Ibaraki, Japan.
Masato Akiba9​National Institute of Animal Health, Ibaraki, Japan.
Kiyoshi Tominaga10​Yamaguchi Prefectural Institute of Public Health and Environment, Yamaguchi, Japan.
Yumi Kirino11​University of Miyazaki, Miyazaki, Japan.
Yuki Kato12​University of Tokyo, Tokyo, Japan.
Katsuhiko Shirahige12​University of Tokyo, Tokyo, Japan.
Tadasuke Ooka13​Kagoshima University, Kagoshima, Japan.
Nozomi Ishijima14​National Institute of Infectious Diseases, Tokyo, Japan.
Ken-Ichi Lee8​National Institute of Animal Health, National Agriculture and Food Research Organization, Ibaraki, Japan.
Sunao Iyoda8​National Institute of Animal Health, National Agriculture and Food Research Organization, Ibaraki, Japan.
Jacques Georges Mainil15​University of Liège, Liège, Belgium.
Tetsuya Hayashi1​Kyushu University, Fukuoka, Japan.
Kyushu University · JPNational Institute of Animal Health · JPFukuoka Institute of Health and Environmental Sciences · JPMiyazaki Prefectural Hospital · JPThe University of Tokyo · JPToyama Institute of Health · JPKagoshima University · JPNational Agriculture and Food Research Organization · JPNational Institute of Infectious Diseases · JPOsaka Prefectural Institute of Public Health · JPTokyo Institute of Technology · JPUniversitair Ziekenhuis Brussel · BEUniversity of Liège · BEUniversity of Miyazaki · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A key virulence factor of enterohaemorrhagic Escherichia coli (EHEC) is the bacteriophage-encoded Shiga toxin (Stx). Stxs are classified into two types, Stx1 and Stx2, and Stx2-producing strains are thought to cause more severe infections than strains producing only Stx1. Although O26 : H11 is the second most prevalent EHEC following O157 : H7, the majority of O26 : H11 strains produce Stx1 alone. However, Stx2-producing O26 strains have increasingly been detected worldwide. Through a large-scale genome analysis, we present a global phylogenetic overview and evolutionary timescale for E. coli O26 : H11. The origin of O26 has been estimated to be 415 years ago. Sequence type 21C1 (ST21C1), one of the two sublineages of ST21, the most predominant O26 : H11 lineage worldwide, emerged 213 years ago from one of the three ST29 sublineages (ST29C2). The other ST21 lineage (ST21C2) emerged 95 years ago from ST21C1. Increases in population size occurred in the late 20th century for all of the O26 lineages, but most remarkably for ST21C2. Analysis of the distribution of stx2-positive strains revealed the recent and repeated acquisition of the stx2 gene in multiple lineages of O26, both in ST21 and ST29. Other major EHEC virulence genes, such as type III secretion system effector genes and plasmid-encoded virulence genes, were well conserved in ST21 compared to ST29. In addition, more antimicrobial-resistance genes have accumulated in the ST21C1 lineage. Although current attention is focused on several highly virulent ST29 clones that have acquired the stx2 gene, there is also a considerable risk that the ST21 lineage could yield highly virulent clones.

Indexed as

AnimalsDrug Resistance, BacterialEnterohemorrhagic Escherichia coliEscherichia coli InfectionsEvolution, MolecularHumansPhylogenyShiga Toxin 2VirulenceVirulence FactorsShiga Toxin 2Virulence Factorsantimicrobial-resistance geneenterohaemorrhagic Escherichia coligenome evolutionpopulation structureShiga toxin

Identifiers

PMID29208163
PMCPMC5729918
OpenAlexW2768790098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.